Using multiomics technologies, Zhang et al. later proved that the combined use of Imatinib and arsenic sulfide from toxic herbal remedy exerted better therapeutic effects in a BCR/ABL-positive mouse model of chronic myeloid leukemia (CML) than either drug as a single agent. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.